![](https://www.taivex.com/wp-content/uploads/2016/09/iStock-1431634510.jpg)
Taivex Therapeutics Corporation will attend Bio Asia-Taiwan 2024
Taivex is dedicated to the development of novel cancer therapeutics and possesses multiple First-in-Class/Best-in-Class anticancer targeted drugs. Taivex will attend the Bio Asia-Taiwan 2024, BIO